01 — At a Glance
The Seed Company That Became a Pesticide Seller (Backwards)
- 52-Week High / Low₹6,540 / ₹4,273
- Q3 Revenue₹11,062 Mn
- Q3 PAT₹957 Mn
- Q3 EPS₹21.29
- Annualised EPS (Q3×4)₹85.16
- Book Value₹695
- Price to Book6.62x
- Dividend Yield2.73%
- Debt / Equity0.03x
- 9M Revenue (H1+Q3)₹45,742 Mn
Auditor’s Opening Note: Bayer CropScience wrapped Q3 FY26 with ₹11,062 million revenue (+4.6% YoY), ₹957 million PAT, and a spectacular 180% YoY profit jump. But here’s the plot twist — crop protection revenues are limping while corn seeds are carrying the team. The company got slapped with ₹104+ million in GST penalties across three orders in the same quarter. P/E at 30.9x is chasing a 24.8% ROCE, which is fine, except the sector median P/E is 23.8x. Overpaying for stability? Or pricing in seed story miracles?
02 — Introduction
Welcome to Bayer’s Crop Casino. Pick a Card: Seeds or Pesticides?
Bayer CropScience makes two things: stuff that kills bugs, and seeds that avoid being killed. One is booming. The other is contemplating life choices.
The company has been around since 1958 when Bayer’s grandfather decided India needed German-engineered insecticides. Then Monsanto got acquired by Bayer globally in 2019, and the two businesses merged in India (NCLT-approved Sept 2019). Now the company sells crop protection solutions (insecticides, fungicides, herbicides) covering ~66% of revenue, hybrid corn seeds covering ~17%, and other stuff covering the rest. Sounds exciting. The stock market has rewarded it with a P/E of 30.9x while the Nifty 500 median sits at 13.3x. That’s 2.3x premium pricing in a market where median is the law.
Q3 FY26 results landed in Feb 2026 with ₹11,062 million in revenue (₹1,106 crore in the old money) and ₹957 million in profit. The profit jumped 180% YoY. Sounds good until you realise Q3 FY25 saw an absolute bloodbath in the profit line (₹7.61 EPS vs ₹33.98 in Q2 FY25). This is a base effect hitting harder than a farmer’s pride in monsoon season.
Leadership transitions happened. CFO Simon Britsch (a German guy who probably made spreadsheets sing) resigned in Feb 2025 due to “repatriation to Bayer AG.” New CFO Vinit Rajesh Jindal stepped in from March 2025. Same month, the company got whacked with GST penalties. Then more penalties. Then more penalties. By December 2025, the company had received ₹104+ million in GST demand notices across FY2018-19 and FY2019-20. The company is appealing. Apparently, the tax department thinks Bayer took too much input tax credit. How… German of them to keep receipts so well.
Concall Whisper (Feb 2026): Management stayed quiet about the GST tsunami in the public call. Figures in the announcements only. This either means they’re confident in the appeal or they’re hoping analysts stop asking questions. Both are concerning.
03 — Business Model: The Schizophrenic Farmer’s Best Friend
Crop Protection Gets Commoditised. Seeds Get Sexy.
Crop protection is the OG business. Buy base chemicals from suppliers, blend them with additives, add packaging, distribute through 4,000+ active dealers, and pray farmers trust the green bottle. Margins compress when commodity prices fall. Upside comes from new molecules and farmer loyalty. Bayer owns the corn seed moat — literally. If you want Bayer corn hybrid seeds in India, there’s no Plan B. That’s ~1st rank in the market. Seeds carry 17% of revenue but way more excitement.
The company operates 1,500+ FPO (Farmer Producer Organisations) partnerships and has reached 5+ lakh smallholders through its network. That’s distribution depth in villages that most FMCG companies only dream about. Better Life Farming (BLF) centers have grown from 10 (2018) to 1,500+ (2023), serving as farmer touchpoints and brand ambassadors. Industrial lubricants? No. Digital farming? Yes — tools to help farmers make better decisions through data. Innovation contributed 20% of business revenue in FY25. The company claims this metric as a superpower. Analysts mostly ignore it.
Crop Protection66%Revenue Mix
Corn Seeds17%Revenue Mix
Others17%Revenue Mix
BLF Centers1,500+Farmer Nodes
Global Parent Note: Bayer group owns 68.58% of Bayer CropScience. That’s strategic control with dividend hostage value. The parent’s global pesticide and seed divisions operate at very different margins than India — they benefit from premium positioning in developed markets. India is the “growth and margin compression” playground.
💬 Real talk: If corn seed genes are the future, why is it only 17% of revenue? Drop your theory in the comments!
04 — Financials Overview
Q3 FY26: The Numbers That Had The Auditors Doing Backflips
Result type: Quarterly Results | Q3 FY26 EPS: ₹21.29 | Annualised EPS (Q3×4): ₹85.16 | 9M Revenue: ₹45,742 Mn (H1 ₹34,680 Mn)
| Metric (₹ Mn) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 11,062 | 10,570 | 15,534 | +4.6% | -28.8% |
| Operating Profit | 1,170 | 206 | 2,003 | +468% | -41.6% |
| OPM % | 11% | 2% | 13% | +900 bps | -200 bps |
| PAT | 957 | 34 | 1,606 | +2,715% | -40.4% |
| EPS (₹) | 21.29 | 0.76 | 35.71 | +2,701% | -40.4% |
The Base Effect Special: Q3 FY25 saw PAT of just ₹34 million (₹0.76 EPS) — basically a rounding error. The company had a tax loss position. Current year, PAT is ₹957 million. That’s not 2,715% magic; that’s a comparison against a ghost quarter. Full-year FY26 EPS annualised at ₹85.16 (Q3×4) vs TTM EPS of ₹149. Expect Q4 to land somewhere in between. Revenue is soft (QoQ down 28.8%) because Q2 was peak season (monsoon+ fertilizer application surge). Q3 is winter — slower sales.
05 — Valuation: Playing the P/E Premium Game
What’s This Company Actually Worth? (Spoiler: Depends Who You Ask)
Join 10,000+ investors who read this every week.
